0
Whales: Giants of the Ocean
Whales: Giants of the Ocean Whales are among the largest and most remarkable animals on Earth. These marine mammals live in oceans around the world, from warm tropical waters to the cold seas...
News & Events
0
Whales: Giants of the Ocean
Whales: Giants of the Ocean Whales are among the largest and most remarkable animals on Earth. These marine mammals live in oceans around the world, from warm tropical waters to the cold seas...
0
Whales: Giants of the Ocean
Whales: Giants of the Ocean Whales are among the largest and most remarkable animals on Earth. These marine mammals live in oceans around the world, from warm tropical waters to the cold seas...
0
Whales: Giants of the Ocean
Whales: Giants of the Ocean Whales are among the largest and most remarkable animals on Earth. These marine mammals live in oceans around the world, from warm tropical waters to the cold seas...
0
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
• Oriva Therapeutics is launched with the support of Asabys, focused on developing innovative therapies in women’s health• The company incorporates two advanced assets from Oncostellae and...
0
Medibiofarma Successfully Completes Phase 2A Clinical Trial of MBF-118 for Fibrotic Crohn’s Disease
Navarra, Spain – August 28, 2025 — Medibiofarma is pleased to announce the successful completion of the industrial research project titled “Investigation of Novel Agonists of the PPAR-γ Receptor...
0
Medibiofarma Receives 2nd Funding Award from the Crohn’s & Colitis Foundation to Support Development of a New Antifibrotic Therapy
Crohn’s & Colitis Foundation’s IBD Ventures Awards Investment to Continue their Support for the Development of Medibiofarma’s Novel First-In-Class PPARg Partial Agonist Oral...
0
Palobiofarma and Medibiofarma open new headquarters in the AINbuilding in Cordovilla, Spain
Palobiofarma and Medibiofarma open new headquarters in the AINbuilding in Cordovilla, Spain · The new facilities, of 200 square meters, consist of an office area next to a fully equipped...
0
Medibiofarma S.L. announced the award of the European CommissionSeal of Excellence for their clinical asset MBF-015.
Navarra – February 2025 – Medibiofarma S.L., a clinical-stage biotechnology company developinga portfolio of new small molecule therapies announced the award of the European CommissionSeal of...
0
First patient dosed in the Phase IIa clinical trial of MBF-015 in patients with Huntington’s disease
Navarra – February 2024 – Medibiofarma S.L., a clinical-stage biotechnology company developing a portfolio of new therapies for the treatment of neurodegenerative diseases and other pathologies...